Dry Eye Challenges & Opportunities
Up to 60% of ophthalmologist patients have some form of ocular surface disease impacting over 60 million Americans.
A Gallop poll of dry eye sufferers shows:
- 72% of patients use an artificial tear.
- 82% wish that there was something more effective to treat dry eye.
- 97% say that their dry eye condition is frustrating.
The discussion starts with the answer to this question posed by James Mazzo: “So why is there such a under-diagnosis of dry eye if your patients are clamoring for some kind of treatment?”
Moderators:
![James Mazzo](https://ois.net/wp-content/uploads/2015/12/James-Mazzo.jpg)
Jim Mazzo
Jim Mazzo is the Executive Chairman and CEO for AcuFocus. AcuFocus specializes in presbyopia correction and is known for its revolutionary KAMRA inlay which was recently FDA approved.
![Ed Holland](https://ois.net/wp-content/uploads/2015/12/Ed-Holland-500x500-website.jpg)
Edward Holland, MD
Dr. Holland is the Director of Cornea Services at Cincinnati Eye Institute and Professor of Clinical Ophthalmology at the University of Cincinnati.
Panelists:
![Eric Donnenfield](https://ois.net/wp-content/uploads/2015/12/Eric-Donnenfield.jpg)
Eric Donnenfeld, MD
Dr. Donnenfeld is a Clinical Professor of Ophthalmology at NYU, Trustee of Dartmouth Medical School, and founding partner of Ophthalmic Consultants of Long Island.
![Vance Thompson](https://ois.net/wp-content/uploads/2015/12/Vance-Thompson.jpg)
Vance Thompson, MD
Vance Thompson, MD is an internationally recognized specialist in Laser Vision Correction and Advanced Cataract Surgery. As a leading international researcher he has played a key role in the development of the most advanced technologies and techniques for both laser and implant vision correction.
![Roger Steinert](https://ois.net/wp-content/uploads/2015/12/Roger-Steinert.jpg)
Roger Steinert, MD
Dr. Steinert’s advanced skill and excellent surgical results have earned him a reputation as an international consultant and leader in cataract surgery, refractive surgery and corneal transplants.